Literature DB >> 27864346

CBX4 Suppresses Metastasis via Recruitment of HDAC3 to the Runx2 Promoter in Colorectal Carcinoma.

Xin Wang1, Liping Li1, Yuanzhong Wu1, Ruhua Zhang1, Meifang Zhang1, Dan Liao1, Gang Wang1, Ge Qin1, Rui-Hua Xu1, Tiebang Kang2.   

Abstract

Polycomb chromobox (CBX) proteins participate in the polycomb repressive complex (PRC1) that mediates epigenetic gene silencing and endows PRC1 with distinct oncogenic or tumor suppressor functions in a cell-type-dependent manner. In this study, we report that inhibition of cell migration, invasion, and metastasis in colorectal carcinoma requires CBX4-mediated repression of Runx2, a key transcription factor that promotes colorectal carcinoma metastasis. CBX4 inversely correlated with Runx2 expression in colorectal carcinoma tissues, and the combination of high CBX4 expression and low Runx2 expression significantly correlated with overall survival, more so than either CBX4 or Runx2 expression alone. Mechanistically, CBX4 maintained recruited histone deacetylase 3 (HDAC3) to the Runx2 promoter, which maintained a deacetylated histone H3K27 state to suppress Runx2 expression. This function of CBX4 was dependent on its interaction with HDAC3, but not on its SUMO E3 ligase, its chromodomain, or the PRC1 complex. Disrupting the CBX4-HDAC3 interaction abolished Runx2 inhibition as well as the inhibition of cell migration and invasion. Collectively, our data show that CBX4 may act as a tumor suppressor in colorectal carcinoma, and strategies that stabilize the interaction of CBX4 with HDAC3 may benefit the colorectal carcinoma patients with metastases. Cancer Res; 76(24); 7277-89. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27864346     DOI: 10.1158/0008-5472.CAN-16-2100

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  36 in total

Review 1.  Runx2, an inducer of osteoblast and chondrocyte differentiation.

Authors:  Toshihisa Komori
Journal:  Histochem Cell Biol       Date:  2018-01-22       Impact factor: 4.304

2.  Targeting histone deacetylase-3 blocked epithelial-mesenchymal plasticity and metastatic dissemination in gastric cancer.

Authors:  Sheng-Mao Wu; Yee-Jee Jan; Shih-Chuan Tsai; Hung-Chuan Pan; Chin-Chang Shen; Cheng-Ning Yang; Shu-Hua Lee; Shing-Hwa Liu; Li-Wei Shen; Chien-Shan Chiu; Jack L Arbiser; Menghsiao Meng; Meei-Ling Sheu
Journal:  Cell Biol Toxicol       Date:  2022-01-01       Impact factor: 6.691

3.  CBX4 contributes to HIV-1 latency by forming phase-separated nuclear bodies and SUMOylating EZH2.

Authors:  Liyang Wu; Ting Pan; Mo Zhou; Tao Chen; Shiyu Wu; Xi Lv; Jun Liu; Fei Yu; Yuanjun Guan; Bingfeng Liu; Wanying Zhang; Xiaohui Deng; Qianyu Chen; Anqi Liang; Yingtong Lin; Lilin Wang; Xiaoping Tang; Weiping Cai; Linghua Li; Xin He; Hui Zhang; Xiancai Ma
Journal:  EMBO Rep       Date:  2022-06-01       Impact factor: 9.071

4.  UHRF1 epigenetically down-regulates UbcH8 to inhibit apoptosis in cervical cancer cells.

Authors:  Qishu Zhang; Lijun Qiao; Xiao Wang; Changkuan Ding; Jason J Chen
Journal:  Cell Cycle       Date:  2018-01-31       Impact factor: 4.534

Review 5.  Vascular mimicry: changing the therapeutic paradigms in cancer.

Authors:  Nazila Fathi Maroufi; Sina Taefehshokr; Mohammad-Reza Rashidi; Nima Taefehshokr; Mahdieh Khoshakhlagh; Alireza Isazadeh; Narmin Mokarizadeh; Behzad Baradaran; Mohammad Nouri
Journal:  Mol Biol Rep       Date:  2020-05-18       Impact factor: 2.316

6.  Use of signals of positive and negative selection to distinguish cancer genes and passenger genes.

Authors:  László Bányai; Maria Trexler; Krisztina Kerekes; Orsolya Csuka; László Patthy
Journal:  Elife       Date:  2021-01-11       Impact factor: 8.140

7.  Long intergenic noncoding RNA00265 promotes proliferation of gastric cancer via the microRNA-144-3p/Chromobox 4 axis.

Authors:  Zengxi Yang; Xi OuYang; Liang Zheng; Lizhen Dai; Wenjuan Luo
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

8.  Evaluation of the prognostic value of CBXs in gastric cancer patients.

Authors:  Mengya He; Limin Yue; Haiyan Wang; Feiyan Yu; Mingyang Yu; Peng Ni; Ke Zhang; Shuaiyin Chen; Guangcai Duan; Rongguang Zhang
Journal:  Sci Rep       Date:  2021-06-11       Impact factor: 4.379

Review 9.  Role of microRNA-129 in cancer and non-cancerous diseases (Review).

Authors:  Bingpeng Deng; Xuan Tang; Yong Wang
Journal:  Exp Ther Med       Date:  2021-06-30       Impact factor: 2.447

10.  Prognosis and Immune Infiltration of Chromobox Family Genes in Sarcoma.

Authors:  Jian Zhou; Ziyuan Chen; Ming Zou; Rongjun Wan; Tong Wu; Yingquan Luo; Gen Wu; Wanchun Wang; Tang Liu
Journal:  Front Oncol       Date:  2021-05-11       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.